Telemonitoring data support postoperative complication prediction
Source check: Source checked. Not independent scientific confirmation.
Finding: Regularized logistic regression combined clinical features, symptom reports and pedometer data to evaluate 30-day complications after cancer surgery. The proof-of-concept study used 52 patients from two pilots and reported an AUROC of 0.74 with nested patient-level cross-validation. Data segments at or after complications were excluded. Small, heterogeneous cohorts and uneven wearable data limit generalizability; clinical intervention benefit was not tested.
Technology: L2-regularized logistic regression
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Regularized supervised learning combines clinical, patient-reported and wearable predictors with patient-grouped tuning/evaluation.
- Test and result
- Nested leave-one-patient-out evaluation of postoperative complications, preserving repeated observations within patient folds.
- Limitation / still unknown
- External replication, real-time deployment and benefit from earlier intervention remain unestablished.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8764868/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary full paper relevant model Methods, study Results and limitations; exact primary front-matter identity and Europe PMC metadata checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.